TREM2 deficiency aggravates α-synuclein-induced neurodegeneration and neuroinflammation in Parkinson's disease models

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Ying GuoHaiyan Lou

Abstract

Variants in the gene encoding the triggering receptor expressed on myeloid cells 2 (TREM2) are known to increase the risk of developing Alzheimer disease and Parkinson's disease (PD). However, the potential role of TREM2 effect on synucleinopathy has not been characterized. In this study, we investigated whether loss of TREM2 function affects α-synucleinopathy both in vitro and in vivo. In vitro, BV2 microglial cells were exposed to α-synuclein (α-syn) in the presence or absence of TREM2 small interference RNA. For in vivo studies, wild-type controls and TREM2 gene knockout mice were intracranially injected in the substantia nigra with adeno-associated viral vectors expressing human α-syn (AAV-SYN) to induce PD. Our results revealed that knockdown of TREM2 aggravated α-syn-induced inflammatory responses in BV2 cells and caused greater apoptosis in SH-SY5Y cells treated with BV2-conditioned medium. In mice, TREM2 knockout exacerbated dopaminergic neuron loss in response to AAV-SYN. Moreover, both in vitro and in vivo TREM2 deficiency induced a shift from an anti-inflammatory toward a proinflammatory activation status of microglia. These data suggest that impairing microglial TREM2 signaling aggravates proinflammatory responses t...Continue Reading

References

Aug 20, 2003·The Journal of Experimental Medicine·Juha PalonevaLeena Peltonen
Mar 26, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Wei ZhangJing Zhang
Sep 27, 2005·Neurobiology of Disease·Alexander GerhardDavid J Brooks
Sep 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Isaiah R TurnbullMarco Colonna
May 4, 2007·The Journal of Clinical Investigation·Antonio Sica, Vincenzo Bronte
Aug 29, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hongwei QinEtty N Benveniste
Sep 7, 2012·Cold Spring Harbor Perspectives in Medicine·V Hugh Perry
Nov 16, 2012·The New England Journal of Medicine·Thorlakur JonssonKari Stefansson
Nov 16, 2012·The New England Journal of Medicine·Rita GuerreiroUNKNOWN Alzheimer Genetic Analysis Group
Aug 6, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kathryn E SheldonSidney M Morris
Apr 12, 2014·Journal of Alzheimer's Disease & Parkinsonism·Rodrigo D PereaRobyn A Honea
Dec 3, 2014·Neuroscience·M S Moehle, A B West
Dec 6, 2014·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Riem GawishSylvia Knapp
Jan 16, 2015·Journal of Parkinson's Disease·Heather E Allen Reish, David G Standaert
Jan 30, 2015·Acta Neuropathologica·Claudia CantoniLaura Piccio
Feb 27, 2015·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Masahito KawaboriMidori A Yenari
Apr 22, 2015·The Journal of Clinical Investigation·Pietro Luigi PolianiMarco Colonna
Sep 5, 2015·Molecular Neurodegeneration·Meghan M PainterGuojun Bu
Nov 12, 2015·Biochemical Pharmacology·Mithilesh Kumar JhaKyoungho Suk
Feb 26, 2016·Nature Reviews. Neuroscience·Marco Colonna, Yaming Wang
Mar 25, 2016·Antioxidants & Redox Signaling·Isabel Lastres-BeckerAntonio Cuadrado
Apr 20, 2016·The Journal of Experimental Medicine·Yaming WangMarco Colonna
Apr 25, 2016·Progress in Neurobiology·Valerie JoersAnna R Carta
Jul 28, 2016·Nature Neuroscience·Richard M Ransohoff
Oct 7, 2016·Frontiers in Molecular Neuroscience·Weidong LeYu Tang
Jan 13, 2017·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Honghua ZhengGuojun Bu
Mar 18, 2017·Frontiers in Cellular Neuroscience·Rosie OwensBarry W McColl
Apr 21, 2017·Neuron·Jason D UlrichDavid M Holtzman
Aug 5, 2017·Molecular Neurodegeneration·Taylor R JayGary E Landreth
Aug 7, 2017·Parkinsonism & Related Disorders·Dennis W Dickson
Oct 27, 2017·Proceedings of the National Academy of Sciences of the United States of America·Cheryl E G LeynsDavid M Holtzman
Apr 6, 2018·Biochemical and Biophysical Research Communications·Youwen ZhangYuhu Zhang
Apr 25, 2018·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Yanhua JiangJun Wang
Sep 13, 2018·Nature Reviews. Neuroscience·Oleg Butovsky, Howard L Weiner

❮ Previous
Next ❯

Citations

Sep 4, 2019·Journal of Neurochemistry·Dafina M Angelova, David R Brown
Feb 8, 2020·Movement Disorders : Official Journal of the Movement Disorder Society·Javier Sánchez-Ruiz de GordoaMaite Mendioroz
Jul 2, 2021·Frontiers in Molecular Neuroscience·Xiaolin ZhuHubin Duan
Sep 1, 2021·Neurobiology of Disease·Robert BrendzaBrad A Friedman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: RNA Regulation

RNA regulation involves several mechanisms that are used by cells to decrease or increase the production of RNA. Disruption of RNA regulatory processes has been associated with Alzheimer's disease (AD). Here are the latest discoveries pertaining to RNA regulation and AD.

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

© 2021 Meta ULC. All rights reserved